Khosla Ventures
-
Artificial Intelligence, BioPharma
‘Digitally native’ pharma Valo Health and Khosla scrap merger plan ahead of vote
Flagship Pioneering’s Valo Health and Khosla Ventures Acquisition Co. abandoned their SPAC merger on the eve of a scheduled shareholder vote on whether to approve the deal. The parties described the decision as mutual, and they cited “market conditions.”
-
Dascena raises $50M in Series B round, publishes data on machine learning in sepsis prediction
A round-up of funding announcements this week. Other companies that have raised new venture capital funding rounds this week include Genespire, HeartVista and Particle Health and Vida.
-
Payer’s Place: Dr. Anil Singh
Dr. Anil Singh shares his insights into the strategies employed by the organization to identify the most effective digital solutions for their members.
-
Karius, using liquid biopsy to detect infectious diseases, raises $165M in Series B round
The SoftBank Vision Fund led the round, which the company said would be used t expand its reach and support future clinical studies.
-
Cognitive health assessment startup Neurotrack raises $21M Series C
The company’s platform consists of a digital assessment to measure memory health and an associated program meant to drive better healthy behaviors and training exercises as a way to improve cognitive health.
-
Nebula Genomics raises $4.3M in seed capital to fund blockchain-based data marketplace
The company plans to use blockchain and other technologies to develop the genomic data marketplace, under a partnership with Veritas Genetics.
-
Iora Health raises $100M with plans to double number of Medicare patients it serves
The funding comes as competition for the Medicare population by startup and growth-stage companies intensifies, not only from other technology-led healthcare organizations like Iora but also from the likes of CVS Health and more established companies like CareMore.
-
Oscar Health raises $165M as health insurance startup’s valuation surpasses $3B
The company has enrolled nearly 250,000 members across six states so far in 2018. Oscar has also projected sales of more than $1 billion in gross premium revenue.
-
Report: Alphabet venture arm GV, Khosla Ventures claim top spots in healthcare investment ranks
Healthcare investments hit $3.8 billion in the second quarter of 2017, marking a spike in these deals and a milestone for the healthcare industry in general, according to StartUp Health’s half year report.
-
Discover the Next-Gen Platform for Integrated Collaborative Care
Beyond EHRs and digital front doors, reducing the gaps in patient care journeys.
-
Neurotrack announces release of its eye-tracking test for Alzheimer’s and $6.5M in funding from Khosla Ventures
Neurotrack has announced the availabilty of its webcam-based test that is aimed to help those with diseases like Alzheimer’s track recognition memory and cognitive function in order to detect risks before behavioral symptoms show up – and it only takes five minutes.
-
HealthTap wins over Khosla and big Series B round
HealthTap has raised $24 million in Series B financing, with Khosla Ventures leading the round. […]